SERVICE 05 / 05
CMC Strategy & Development Advisory
Connect scientific findings with a clear development, regulatory and manufacturing plan.
TeraCrystal offers CMC advisory support in collaboration with Dr. Matthias Gerlach, combining specialist solid-state expertise with experience across pharmaceutical development, technical operations and manufacturing.
The Development Question
What needs to happen next to move a promising compound or development programme towards clinical supply and commercialization? Which technical and regulatory CMC gaps need attention, and which capabilities should be provided by external partners?
Scope of Support
Phase-appropriate CMC roadmaps from early development to commercialization, including gap assessments, priorities, milestones and coordination of drug-substance and drug-product activities.
Preparation and review of CMC documentation for IND, IMPD, NDA and MAA submissions; preparation for scientific advice and regulatory meetings; and lifecycle planning for changes and variations.
Definition of technical requirements, evaluation of potential partners and proposals, and support with project governance, performance reviews and technical escalation.
Assessment of process knowledge, documentation and receiving-site capabilities, with support for scale-up planning, transfer activities and clinical or commercial supply readiness.
Assessment of development programmes, manufacturing arrangements, technical risks and investment requirements to support partnering and investment decisions.
Project scope may include small molecules and selected biologics programmes, depending on the technical requirements and expertise needed.
Our Approach
We start with the development stage, the available data and the decisions the client needs to make. Together, we define a focused scope and connect specialist investigations with the wider CMC programme.
Where relevant, TeraCrystal's solid-state and crystallization work can be integrated with advisory support on development priorities, documentation, technology transfer and manufacturing strategy.
Potential Project Outputs
Depending on the agreed scope, outputs may include a CMC roadmap, a technical gap assessment, a regulatory CMC document review, a CDMO evaluation, a technology-transfer readiness assessment or a technical due diligence report.
Relevant Experience
Dr. Matthias Gerlach contributes experience in CMC strategy, technical operations, GMP manufacturing, CDMO and supply-chain management, regulatory CMC and technical due diligence, including work involving biologics.
Discuss Your Challenge
An unexpected solid form, an unresolved structure or a crystallization question may require a focused scientific investigation. Tell us what you know about the material, what remains uncertain and which development decision you need to make.